Ozempic: Who It Works For in Weight Loss and Diabetes

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that regulates appetite and blood sugar levels. Originally developed for type 2 diabetes, clinical trials showed it also produces significant weight loss—an average of 15% body weight reduction in one landmark study. Understanding who benefits most from this medication can help you decide if it's right for your health goals.

How Semaglutide Works in Your Body

Semaglutide activates GLP-1 receptors in the brain, pancreas, and digestive tract. When these receptors activate, they send signals that slow stomach emptying, increase feelings of fullness, and improve how your pancreas releases insulin. This triple action addresses the core mechanisms behind both weight gain and blood sugar imbalance, which is why it works across two separate conditions.

The medication also affects the hunger centers in your hypothalamus, reducing cravings and making portion control feel natural rather than forced. Most patients report that food simply becomes less appealing within the first 1–2 weeks of treatment. This neurological shift explains why semaglutide produces weight loss even when diet alone has failed in the past.

Who Sees the Most Benefit from Semaglutide

Semaglutide works best for people with a BMI of 27 or higher who also have weight-related health conditions, or a BMI of 30 or higher regardless of other factors. Patients with type 2 diabetes often see dual benefits: improved A1C levels (blood sugar control) and weight loss that can reduce or eliminate the need for other diabetes medications. People who struggle with emotional eating, frequent cravings, or constant hunger often experience the most dramatic relief.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Clinical Evidence: Weight Loss and Diabetes Outcomes

The STEP trials demonstrated that semaglutide produces sustained weight loss across 68 weeks of treatment, with participants losing 10–15% of their starting body weight compared to 2–3% with lifestyle changes alone. For people with type 2 diabetes, the SUSTAIN trials showed A1C reductions of 1.5–1.8 percentage points, often allowing patients to reduce or discontinue other medications. These outcomes remain consistent across diverse age groups and ethnic backgrounds.

Long-term follow-up data shows that weight loss is maintained as long as treatment continues, and regain occurs gradually after stopping the medication. This pattern aligns with how the body's appetite-control system works: semaglutide restores normal signaling, but the underlying genetic and metabolic predispositions remain. Continuing treatment—rather than viewing it as temporary—produces the best health outcomes.

Side Effects, Tolerability, and Who Should Avoid Semaglutide

Common side effects include nausea, vomiting, diarrhea, and constipation, especially in the first 2–4 weeks. Most patients report these effects are mild and resolve as the body adapts. Gradual dose increases (called titration) reduce the severity of nausea compared to starting at higher doses. Staying hydrated and eating small, frequent meals help manage gastrointestinal symptoms.

Semaglutide is not recommended for people with a personal history of medullary thyroid cancer, a family history of multiple endocrine neoplasia type 2, or severe pancreatitis. Pregnant individuals and those planning pregnancy should not use it. People with a history of gallbladder disease, kidney problems, or severe dehydration require medical supervision. PlexusDx clinicians screen for these contraindications during your initial consultation.

Compounded Semaglutide vs. Brand-Name: Cost and Accessibility

Brand-name semaglutide (Ozempic for diabetes, Wegovy for weight loss) costs $900–$1,300 per month without insurance and often requires prior authorization even with coverage. PlexusDx sources semaglutide from licensed 503A compounding pharmacies, reducing cost to $189/month while maintaining the same active ingredient and potency. Your dose may need to go up. Your price won't.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will semaglutide work if I've tried other weight loss medications before?

Yes. Semaglutide uses a different mechanism (GLP-1 receptor activation) than older weight loss drugs like phentermine or orlistat, so prior treatment failure does not predict poor response to semaglutide. Many patients see significant results even after unsuccessful attempts with other medications. Your genetic profile and current metabolic state matter more than past history.

How quickly will I see weight loss on semaglutide?

Most patients notice appetite reduction within 1–2 weeks, but measurable weight loss typically appears after 3–4 weeks of treatment. Average weight loss accelerates between weeks 8–16 as your body adapts to the medication. Full results from a given dose usually emerge after 4 weeks of consistent use at that dose level.

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic or Wegovy?

Yes. PlexusDx compounded semaglutide contains the same active pharmaceutical ingredient, manufactured at licensed 503A compounding pharmacies that meet strict FDA and state pharmacy board standards. Efficacy depends on the ingredient itself, not the brand label. The main difference is cost: PlexusDx is $189/mo month-to-monthnth versus $900–$1,300 for brand versions.

Can I use semaglutide if I have type 1 diabetes?

Semaglutide is approved only for type 2 diabetes, not type 1. People with type 1 diabetes have an autoimmune condition that destroys insulin-producing cells, and semaglutide does not address that underlying mechanism. Using it in type 1 diabetes increases the risk of diabetic ketoacidosis. Consult your endocrinologist before considering any GLP-1 medication if you have type 1 diabetes.

What does the PlexusDx Precision Peptide Genetic Test tell me about semaglutide response?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.